Promising research may lead to therapies that help prevent colitis-induced cases of colon cancer.
A new study suggests that patient participation in brief psycho-educational classes may reduce the severity of symptoms in some patients suffering from irritable bowel syndrome (IBS).
Mauna Kea Technologies, leader in the optical biopsy market and developer of Cellvizio®, the fastest way to see cancer, announced recently that Cellvizio procedures in the upper GI tract have been added to the Ambulatory Surgical Center (ASC) approved procedure list.
A natural safety mechanism in the colon impedes development of adenomas, according to scientists at the Institute for Research in Biomedicine (IRB) in Barcelona, Spain.
These innovations herald developments in colon cancer detection.
Microbes in the human gut may prove to be the key to future therapies for much more than gastrointestinal disorders.
There seemed to be no options. After undergoing an organ transplant, the patient was prescribed high-dose immunosuppressants, which facilitated acceptance of the donated organ but also crippled the patient’s infection-fighting mechanisms. The muted immune response allowed Clostridium difficile (C. diff) bacteria to disrupt the patient’s gut bacterial balance.
By focusing on the detection of colon polyps, surgeons at Lehigh Valley Colon and Rectal Specialists draw on their research experience and ongoing innovations to prevent colon cancer.
For the longtime Chief of the Division of Gastroenterology at Easton Hospital, the decision to formally join forces with the hospital is an endorsement both of Easton’s collaborative atmosphere and of its commitment to excellent care.